Indoxyl sulfate (IS) and p-cresyl sulfate (pCS) are two important gut microbiota–generated protein-bound uremic toxins. The present study aims to explore the alterations of serum IS and pCS concentrations, their production, and daily removal in end-stage renal disease (ESRD).